V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20069324 | 20157629 | 1.51 | 79.9 | null | 2019-05-05 | 2019-06-28 | Derazantinib | 02 | Y | CYCLOPHOSPHAMIDE + POMALIDOMIDE | 100851664 |
| 20069583 | 20157630 | 1.65 | 58.7 | Neo-adjuvant (N) | 2019-10-01 | 2019-10-02 | Azacitidine | 01 | N | INTERAACT TRIAL | 100113393 |
| 20069791 | 20157631 | 1.91 | 46 | Palliative (P) | 2021-04-09 | 2021-04-28 | COSMIC TRIAL | 02 | N | BENDAMUSTINE + RITUXIMAB | 100948501 |
| 20070046 | 20157632 | null | null | null | null | 2021-11-28 | FOCUS4 TRIAL | null | N | BEVACIZUMAB + FLUOROURACIL + IRINOTECAN | 101510317 |
| 20070190 | 20157633 | 1.87 | 48.2 | Curative (C) | 2019-08-06 | 2021-01-01 | null | 02 | N | COSMIC TRIAL | 100869083 |
| 20070259 | 20157634 | 1.84 | 100 | null | 2019-01-10 | 2019-01-14 | Rituximab | 02 | null | DERAZANTINIB | 101470311 |
| 20070301 | 20157635 | 1.57 | 81.1 | Curative (C) | 2019-04-05 | 2019-04-26 | Topotecan (intravenous) | 2 | null | CAPECITABINE + OXALIPLATIN + TRASTUZUMAB | 100523326 |
| 20070382 | 20157636 | 1.56 | 84.2 | Palliative (P) | 2017-06-17 | 2017-06-23 | IBRUTINIB | N | N | BORTEZOMIB + PANOBINOSTAT | 100340739 |
| 20070446 | 20157637 | 1.69 | 79.6 | 03 | 2022-02-05 | 2022-02-16 | Gemcitabine + Oxaliplatin | null | N | CAPECITABINE + CISPLATIN + STREPTOZOCIN | 100303847 |
| 20070652 | 20157638 | 1.52 | 73.9 | Palliative (P) | 2019-12-17 | 2020-05-14 | CISPLATIN + TEYSUNO | 02 | N | IRINOTECAN + MDG + PANITUMUMAB | 101336423 |
| 20070752 | 20157639 | 1.53 | 84.8 | Palliative (P) | 2020-02-13 | 2020-02-13 | Binimetinib + Encorafenib | 02 | null | CAPECITABINE + STREPTOZOCIN | 101258011 |
| 20073014 | 20157640 | 1.81 | 73.75 | Palliative (P) | 2022-03-27 | 2022-04-24 | PERTUZUMAB + TRASTUZUMAB | 02 | N | BORTEZOMIB + DARATUMUMAB + THALIDOMIDE | 100024561 |
| 20073374 | 20157641 | null | null | Palliative (P) | null | 2021-11-30 | TEMOZOLOMIDE | Y | null | CHOP R | 101601864 |
| 20073763 | 20157642 | 1.53 | 66.9 | Palliative (P) | 2022-04-27 | 2022-05-16 | Rituximab | 02 | null | ECF | 100780633 |
| 20075366 | 20157644 | 1.75 | 62.2 | Curative (C) | 2021-01-21 | 2021-01-22 | ATEZOLIZUMAB + CARBOPLATIN + ETOPOSIDE | null | N | CABAZITAXEL | 100783629 |
| 20078310 | 20157646 | 1.48 | 71.9 | null | null | 2017-03-13 | NB Rel CCLG guidelines Irin & Temoz | 02 | null | MITOMYCIN | 100647413 |
| 20078460 | 20157647 | 1.65 | 118.6 | null | 2018-02-09 | 2019-02-01 | Cisplatin + Docetaxel +Fluorouracil | 01 | N | GEMCARBO | 100966912 |
| 20078985 | 20157648 | 1.66 | 46.3 | Palliative (P) | 2019-06-22 | 2019-06-28 | Hydroxycarbamide | 02 | N | CARBOPLATIN + PEMBROLIZUMAB + PEMETREXED | 100782911 |
| 20079923 | 20157649 | 1.62 | 64 | Palliative (P) | 2017-01-20 | 2018-05-15 | FOCUS4 TRIAL | 2 | null | CISPLATIN + DOCETAXEL | 101127750 |
| 20080353 | 20157650 | 1.57 | 71.5 | Palliative (P) | 2020-02-21 | 2020-02-21 | CISPLATIN + VINORELBINE | 02 | null | CISPLATIN + DOCETAXEL + FLUOROURACIL | 100887597 |
| 20080378 | 20157651 | 1.81 | 14.5 | Palliative (P) | 2021-11-10 | 2021-11-20 | CISPLATIN + TEYSUNO | 02 | null | CARBOPLATIN + CYCLOPHOSPHAMIDE + DOXORUBICIN + PACLITAXEL | 101406107 |
| 20082569 | 20157653 | 1.53 | 54.5 | null | 2020-11-16 | 2020-12-08 | Bevacizumab + CAPECITABINE + OXALIPLATIN | 02 | N | DOCETAXEL + NINTEDANIB | 100547969 |
| 20084150 | 20157655 | 1.69 | 101.3 | Palliative (P) | 2017-03-30 | 2017-04-06 | Atezolizumab | 02 | null | BINIMETINIB + ENCORAFENIB | 100861511 |
| 20084733 | 20157657 | 1.78 | 62.7 | Palliative (P) | 2022-01-08 | 2022-01-13 | IDELALISIB + RITUXIMAB | 02 | N | ECARBOX | 100461725 |
| 20084757 | 20157658 | 1.6 | null | null | 2019-03-06 | 2019-03-13 | Rituximab (INTRAVENOUS Maintenance) | 02 | null | IRINOTECAN + MDG + PANITUMUMAB | 100877133 |
| 20085579 | 20157660 | 0 | 67.8 | Palliative (P) | 2015-12-02 | 2016-04-15 | BCG Intravesical | 02 | null | IBRUTINIB | 100299022 |
| 20086771 | 20157661 | 1.81 | 63.6 | null | 2019-01-18 | 2019-02-06 | EC | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + VINCRISTINE | 101664916 |
| 20086794 | 20157662 | 1.54 | 73.4 | null | 2020-01-15 | 2020-01-18 | FOXTROT TRIAL | 02 | N | CYCLOPHOSPHAMIDE + TOPOTECAN | 100342773 |
| 20090331 | 20157663 | 1.71 | 72.2 | null | 2018-05-06 | 2018-05-20 | SCOPE 2 TRIAL | 02 | N | POMALIDOMIDE | 101204687 |
| 20091883 | 20157665 | 1.75 | 80 | Palliative (P) | 2020-07-17 | 2020-07-17 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | MITOMYCIN | 101495733 |
| 20092119 | 20157666 | 1.65 | 46 | Palliative (P) | 2022-02-14 | 2022-03-03 | FCarboSt | 02 | null | ERIBULIN | 101310999 |
| 20092200 | 20157667 | 1.58 | 94 | Adjuvant (A) | null | 2019-09-02 | CHOP R - 21 days | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100191475 |
| 20092250 | 20157668 | 1.84 | 91.9 | null | null | 2020-02-14 | null | 02 | null | ECF | 101555793 |
| 20092372 | 20157669 | 1.56 | 0 | 03 | null | 2021-09-07 | null | null | null | EPIRUBICIN + FLUOROURACIL + OXALIPLATIN | 101615191 |
| 20092505 | 20157670 | 1.8 | 72.2 | Neo-adjuvant (N) | 2016-04-24 | 2016-05-08 | Etoposide + Ifosfamide (5 days) | 02 | N | OXALIPLATIN + MDG + PANITUMUMAB | 100962493 |
| 20092564 | 20157671 | 1.69 | 18.5 | Palliative (P) | 2022-03-20 | 2022-03-20 | CYCLOPHOSPHAMIDE + GEMCITABINE + RITUXIMAB + VINCRISTINE | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100064765 |
| 20094404 | 20157673 | 1.52 | 0 | Palliative (P) | 2018-12-12 | 2019-04-16 | Liposomal Doxorubicin (Caelyx) | null | N | BEAM | 101436212 |
| 20095247 | 20157674 | 1.81 | 63 | null | 2017-07-15 | 2017-07-15 | Bortezomib + Daratumumab | 02 | Y | HYDROXYCARBAMIDE | 100658896 |
| 20095656 | 20157676 | 1.55 | 74.7 | null | 2021-07-21 | 2021-10-19 | Bevacizumab + Cape + Irino 14day | 02 | N | MCX | 100480046 |
| 20098699 | 20157677 | 1.51 | 69.8 | null | 2019-11-03 | 2019-11-03 | PHITT Trial | 02 | N | GEMCARBO | 101156006 |
| 20098972 | 20157678 | 1.65 | 59.9 | null | 2021-02-08 | 2021-02-14 | Hydroxycarbamide | 02 | null | BORTEZOMIB | 100251449 |
| 20099293 | 20157679 | 1.58 | null | Palliative (P) | 2021-12-05 | 2021-12-23 | RAMUCIRUMAB | 02 | Y | CYCLOPHOSPHAMIDE + DACTINOMYCIN + VINCRISTINE | 101037736 |
| 20102709 | 20157681 | 1.89 | 94 | 03 | 2018-11-10 | 2018-11-10 | Bortezomib +/- Dexamethasone | 2 | N | BORTEZOMIB + THALIDOMIDE | 100699180 |
| 20102753 | 20157682 | 1.84 | 75.5 | null | 2021-12-14 | 2021-12-14 | Bevacizumab + Capecitabine | 02 | N | CAPECITABINE + CISPLATIN + STREPTOZOCIN | 101169511 |
| 20103311 | 20157683 | 1.82 | 101.4 | 03 | 2020-02-18 | 2020-02-18 | Chlorambucil | 02 | N | SCOPE2 TRIAL | 100700222 |
| 20104579 | 20157684 | null | null | Palliative (P) | null | 2019-06-06 | FOCUS4 TRIAL | 02 | N | ARSENIC TRIOXIDE + TRETINOIN | 101197827 |
| 20104849 | 20157686 | 1.75 | 85 | 03 | null | 2021-12-06 | Chlorambucil | N | N | CYTARABINE | 101653900 |
| 20104903 | 20157687 | null | null | Palliative (P) | 2021-04-23 | 2021-05-06 | CARFILZOMIB + LENALIDOMIDE | 02 | null | ACALABRUTINIB | 101304581 |
| 20105167 | 20157688 | 1.6 | 70 | Palliative (P) | 2021-01-05 | 2021-01-15 | CISPLATIN + FLUOROURACIL + Trastuzumab | 02 | N | CAPECITABINE + OXALIPLATIN + PEMBROLIZUMAB | 101586936 |
| 20105807 | 20157690 | 1.64 | 73.1 | Palliative (P) | 2020-10-01 | 2020-10-18 | COSMIC TRIAL | 02 | N | BEVACIZUMAB + FLUOROURACIL + IRINOTECAN | 100908438 |